Retinoids and Apoptosis

Advances in Organ Biology

Volumn 3, Issue C, 1997, Pages 161-196

  Zhang, Li Xin ^a   Jetten, Anton M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345714424     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(08)60056-7     Document Type: Article

References (197)

1. Adachi, H., & Jetten, A. M. (1996). Unpublished observations
2. Adachi H., Preston G., Harvat B., Dawson M.I., and Jetten A.M. Inhibition of cell proliferation and induction of apoptosis by the retinoid CD437 in human lung carcinoma cells. Am. J. Respir. Cell Mol. Biol. (1997) Submitted
3. Aeschlimann D., Kaupp O., and Paulsson M. Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate. J. Cell Biol. 129 (1995) 881-892
4. Anzai N., Kawabata H., Hirama T., Masutani H., Ohmori M., Yoshida Y., and Okuma M. Marked apoptosis of human myelomonocytic leukemia cell line P39: significance of cellular differentiation. Leukemia 8 (1994) 446-453
5. Apfel C., Crettaz B.M., Forni L., Kamber M., Kaufmann F., LeMotte P., Pirson W., and Klaus M. A RA receptor a antagonist selectively counteracts RA effects. Proc. Natl. Acad. Sci. USA 89 (1992) 7129-7133
6. Atencia R., Garcia-Sanz M., Unda F., and Arechaga J. Apoptosis during RA-induced differentiation of F9 embryonal carcinoma cells. Exp. Cell Res. 214 (1994) 663-667
7. Beato M., Herrlich P., and Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell 83 (1995) 851-857
8. Benedetti L., Grignani F., Scicchitano B.M., Jetten A.M., Diverio D., Lo Coco F., Awisati C., Gambacorti-Passerini C., Adamo S., Levin A., Pelicci P.G., and Nervi C. Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARα-mediated increase of type II transglutaminase. Blood 87 (1996) 1939-1950
9. Benito A., Grillot D., Nunez G., and Fernandez-Luna J.L. Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Am. J. Pathol. 146 (1995) 481-490
10. Benner S.M., Lippmann S.E., and Hong W.K. Chemoprevention of lung cancer. Chest 107 (1995) 316S-321S
11. Ben-Sasson S.A., Sherman Y., and Gavrieli Y. Identification of dying cells: In situ staining. Methods Cell Biol. 46 (1995) 29-39
12. Bhatnagar R., Abou-Issa H., Curley R.W., Koolemans-Beynen A., Moeschberger M.L., and Webb T.E. Growth suppression of human carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate. Biochem Pharmacol. 41 (1991) 1471-1477
13. Boehm M.F., Zhang L., Zhi L., McClurg M.R., Berger E., Wagoner M., Mais D.E., Suto C.M., Davies P.J.A., Heyman R.A., and Nadzan A.M. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J. Med. Chem. 38 (1995) 3146-3155
14. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., and Thompson C.B. Bcl-X, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74 (1993) 597-608
15. Boise L.H., Gottschalk A.R., Quintans J., and Thompson C.B. Bcl-2 and Bcl-2-related proteins in apoptosis regulation. Curr. Top. Microbiol. Immunol. 200 (1995) 107-121
16. Boylan J.F., Lufkin T., Achkar C.C., Chambon P., and Gudas L.J. Targeted disruption of retinoic acid receptor a (PAPα) and RARγ results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol. cell. Biol. 15 (1995) 851-853
17. Bruel A., Benoit G., De-Nay D., Brown S., and Lanotte M. Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis RA induces apoptosis independent of maturation and Bcl-2 expression. Leukemia. 9 (1995) 1173-1184
18. Bunce C.M., Wallington L.A., Harrison P., Williams G.R., and Brown G. Treatment of HL60 cells with various combinations of retinoids and 1 alpha,25 dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis. Leukemia. 9 (1995) 410-418
19. Chawla A., and Lazar M.A. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc. Natl. Acad. Sci. USA 91 (1994) 1786-1790
20. Chen J.D., and Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377 (1995) 454-457
21. Cheng A.L., Su I.J., Chen C.C., Tien H.F., Lay J.D., Chen B.R., Pu Y.S., Hong R.L., Shen M.C., and Wang C.H. Use of RA in the treatment of peripheral T-cell lymphoma: a pilot study. J. Clin. Oncol. 12 (1994) 1185-1192
22. Chiesa F., Tradati N., Marazza M., Rossi N., Boracchi P., Mariani L., Clerici M., Formelli F., Barzan A., Carrassi L., Pastorini A., Camerini T., Giardini R., Zurrida S., Minn F.L., Costa A., De Palo G., and Veronesi U. Prevention of relapses and new localizations of oral leukoplakias with the synthetic retinoid fenretinide (4-4-HPR). Preliminary results. Oral Oncol. Eur. J. Cancer 28B (1992) 97-103
23. 53-dependent apoptosis. Mol. Cell. Biol. 14 (1994) 2556-2563
24. Collins S.J., Robertson K.A., and Mueller L. RA-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the RA receptor (RAR-α). Mol. Cell. Biol. 10 (1990) 2154-2163
25. Corbeil J., Rapaport E., Richman D.D., and Looney D.J. Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells. J. Clin. Invest. 93 (1994) 1981-1986
26. Costa A., Formelli F., Chiesa F., Decensi A., De Palo G., and Veronesi U. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res. 54 (1994) 2032s-2037s Suppl.
27. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz M.A., Lassota P., and Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 13 (1992) 795-808
28. Darzynkiewicz Z. Apoptosis in antitumor strategies: modulation of cell cycle or differentiation. J. Cell Biochem. 58 (1995) 151-159
29. Davies P.J.A., Stein J.P., Chiocca E.A., Basilion J.P., Gentile V., Thomazy V., and Fesus L. Retinoid-regulated expression of transglutaminases: links to the biochemistry of programmed cell death. In: Morriss-Kay G. (Ed). Retinoids in Normal Development and Teratogenesis (1992), Oxford University Press, New York 249-263
30. D'Amico A.V., and McKenna W.G. Apoptosis and a re-investigation of the biologic basis for cancer therapy. Radiother. Oncol. 33 (1994) 3-10
31. Delescluse C., Cavey M.T., Martin B., Bernard B.A., Reichert U., Maignan J., Darmon M., and Shroot B. Selective high affinity RA receptor α or β-γ ligands. Mol. Pharmacol. 40 (1991) 556-562
32. Delia D., Aiello A., Formelli F., Fontanella E., Costa A., Miyashita T., Reed J.C., and Pierotti M.A. Regulation of apoptosis induced by the retinoid N-(4-hydroxy-phenyl) retinamide and effect of deregulated bcl-2. Blood. 85 (1995) 359-367
33. Delia D., Aiello A., Lombardi L., Pelicci P.G., Grignani F., Grignani F., Formelli F., Menard A., Costa S., Veronesi U., and Pierotti M.A. N-(4-hydroxyphenyl) retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to RA. Cancer Res. 53 (1993) 6036-6041
34. De Luca L.M. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J. 5 (1991) 2924-2933
35. De Palo G., Veronesi U., Camerini T., Formelli F., Mascotti G., and Boni C. Can fenretinide protect women against ovarian cancer? J. Natl. Cancer Inst. 87 (1995) 146-147
36. de Thé H., Lavau C., Marchio A., Chomienne C., Degos L., and Dejean A. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66 (1991) 675-684
37. 53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10 (1990) 5772-5781
38. Di Vinci A., Geido E., Infusini E., and Giaretti W. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide. Int. J. Cancer 59 (1994) 422-426
39. Earnshaw W.C. Nuclear changes in apoptosis. Curr. Opin. Cell Biol. 7 (1995) 337-343
40. 2+ associated with apoptosis. Methods Cell Biol. 46 (1995) 41-56
41. Eitan S., and Schwartz M. A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science 261 (1993) 106-108
42. 53. BioEssays 17 (1995) 923-930
43. Enari M., Hug H., and Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375 (1995) 78-81
44. Evan G.I., Wyllie A.H., Gibert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., and Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69 (1992) 119-128
45. Evan G., Brown L., Whyte M., and Harrington E. Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 7 (1995) 825-834
46. Evans R.M. The steroid and thyroid receptor superfamily. Science 240 (1988) 889-895
47. Fanjul A., Dawson M.I., Hobbs P.D., Jong L., Cameron J.F., Harlev E., Graupner G., Lu X.P., and Pfahl M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372 (1994) 107-111
48. Ferretti P., and Geraudie J. RA-induced cell death in the wound epidermis of regenerating zebrafish fins. Dev. Dyn. 202 (1995) 271-283
49. Fesus L., Thomazy V., and Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 224 (1987) 104-108
50. Fesus L., Thomazy V., Autuori F., Ceru M.P., Tarcsa E., and Piacentini M. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett. 245 (1989) 150-154
51. Fesus L., Davies P.J.A., and Piacentini M. Apoptosis: molecular mechanisms in programmed cell death. Eur. J. Cell Biol. 56 (1991) 170-177
52. Fesus L. Biochemical events in naturally occurring forms of cell death. FEBS Lett. 328 (1993) 1-5
53. Fesus L., Szondy Z., and Uray I. Probing the molecular program of apoptosis by cancer chemopreventive agents. J. Cell. Biochem. (1995) 151-161 Suppl., 22
54. Fisher D.E. Apoptosis in cancer therapy: crossing in the threshold. Cell 78 (1994) 539-542
55. Folk J.E. Transglutaminases. Annu. Rev. Biochem. 49 (1980) 517-531
56. Formelli F., and Cleris L. Synthetic retinoid fenretinide is effective against human ovarian carcinoma xenograft and potentiates cis-platin activity. Cancer Res. 53 (1993) 5374-5376
57. Fukuda K., Kojiro M., and Chiu J.-F. Differential regulation of tissue transglutaminase in rat hepatoma cell lines McA-RH7777 and McA-RH8994: relation to growth rate and cell death. J. Cell. Biochem. 54 (1994) 67-77
58. Gandrillon O., Ferrand N., Michaille J.J., Roze L., Zile M.H., and Samarut J. C-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene. Oncogene 9 (1994) 749-758
59. Glass C.K. Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocrine Rev. 15 (1994) 391-407
60. Gebert J.F., Moghal N., Frangioni J.V., Sugarbaker D.J., and Neel B.G. High frequency of retinoic acid reeptor β abnormalities in human lung cancer. Oncogene 6 (1991) 1859-1868
61. Giguère V. RA receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocrine Rev. 15 (1994) 61-79
62. Gold R. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing translation techniques. Lab. Invest. 71 (1994) 219-233
63. Green D.R., and Martin S.J. The killer and the executioner: how apoptosis controls malignancy. Curr. Opin. Immunol. 7 (1995) 694-703
64. Grignani F., Ferrucci P.F., Testa U., Talamo G., Fagioli M., Alcalay M., Mencarelli A., Grignani F., Peschle C., Nicoletti I., and Pelicci P.G. The acute promyelocytic leukemia-specific PML-RARα Fusion protein inhibits differentiation and promotes survival of meyloid precusor cells. Cell 74 (1993) 423-431
65. Gudas L.J., Sporn M.B., and Roberts A.B. Cellular biology and biochemistry of the retinoids. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds). The Retinoids: Biology, Chemistry, and Medicine. (1994), Raven Press, New York 443-520
66. 21 Cdk-interacting protein Cip 1 is a potent inhibitor of Gl cyclin-dependent kinases. Cell 75 (1993) 805-816
67. Hawkins C.J., and Vaux D.L. Analysis of the role of bcl-2 in apoptosis. Immunol. Rev. 142 (1994) 127-139
68. Helmberg A., Auphan N., Caelles C., and Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 14 (1995) 452-460
69. Hengartner M.O., and Horvitz H.R. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76 (1994) 665-676
70. Hengartner M.O., and Horvitz H.R. Programmed cell death in Caenorhabditis elegans. Curr. Opin. Genet. Dev. 4 (1994) 581-586
71. Heyman R.A., Mangelsdorf D.J., Dyck J.A., Stein R.B., Eichele G., Evans R.M., and Thaller C. 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68 (1992) 397-406
72. Hockenbery D., Nunez G., Milliman C., Schreiber R.D., and Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348 (1990) 334-336
73. Holbrook K.A., and Hennings H. Phenotypic expression of epidermal cells in vitro: a review. J. Invest. Dermatol. 81 (1983) 11S-24S
74. Horie M., and Broxmeyer H.E. The combination of Steel factor and GM-CSF blocks apoptosis induced by RA and upregulates AP-1 in a human growth factor-dependent cell line. Exp. Hematol. 23 (1995) 168-173
75. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurakawa R., Ryan A., Kamie Y., Soderstrom M., Glass C.K., and Rosenfeld M.G. Ligand-dependent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377 (1995) 397-404
76. Howard M.K., Burke L.C., Mailhos C., Pizzey A., Gilbert C.S., Lawson W.D., Collins M.K., Thomas N.S., and Latchman D.S. Cell cycle arrest of proliferating neuronal cells by serum deprivation can result in either apoptosis or differentiation. J. Neurochem. 60 (1993) 1783-1791
77. Hsieh T.C., Ng C., and Wu J.M. The synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) exerts antiproliferative and apoptosis-inducing effects in die androgen-independent human prostatic JCA-1 cells. Biochem. Mol. Biol. Int. 37 (1995) 499-506
78. Igawa M., Tanabe T., Chodak G.W., and Rukstalis D.B. N-(4-hydroxyphenyl)retinamide induces cell cycle specific growth inhibition in PC3 cells. Prostate 24 (1994) 299-305
79. Itoh N., and Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268 (1993) 10932-10937
80. Iwata M., Mukai M., Nakai Y., and Iseki R. RAs inhibit activation-induced apoptosis in T cell hybridomas and thymocytes. J. Immunol. 149 (1992) 3302-3308
81. James S.Y., Mackay A.G., and Colston K.W. Vitamin D derivatives in combination with 9-cis RA promote active cell death in breast cancer cells. J. Mol. Endocrinol. 14 (1995) 391-394
82. Jetten A.M., Fujimoto W., Zhang L.X., Marvin K.W., Austin S., Mills K.J., Bernacki S.H., and Saunders N.A. Retinoic acid receptors and the regulation of gene expression in tracheobronchial epithelial cells. In: Livrea M.A., and Vidali G. (Eds). Retinoids: From Basic Science to Clinical Applications. (1994), Birkhauser Verlag, Basel 243-252
83. Jetten A.M., Nervi C., and Vollberg T.M. Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids. J. Natl. Cancer Inst. Monogr. 13 (1992) 93-100
84. Jiang H., Gyda M., Harnish D.C., Chandraratna R.A., and Soprano K.J. Teratogenesis by retinoic acid analogs positively correlates with elevation of retinoic acid receptor-beta2 mRNA levels in treated embryos. Teratology 50 (1994) 38-43
85. Jiang H., and Kochhar D.M. Induction of tissue transglutaminase and apoptosis by retinoic acid in the limb bud. Teratology 46 (1992) 333-340
86. Kakizuka A., Miller W.H., Umesono K., Warrell R.P., Frankel S.R., Murty V.V.V.S., Dmitrovsky E., and Evans R.M. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66 (1991) 663-674
87. Kalemkerian G.P., Slusher R., Sakkaraiappan R., Gadgeel S., and Mabry M. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J. Natl. Cancer Inst. 87 (1995) 1674-1680
88. Kastner P., Mark M., and Chambon P. Nonsteroid nuclear receptors: What are the genetic studies telling us about their role in real life?. Cell 83 (1995) 859-869
89. King K.L., and Cidlowski J.A. Cell cycle and apoptosis: common pathways to life and death. J. Cell Biochem. 58 (1995) 175-180
90. Knight R.L., Hand D., Piacentini M., and Griffin M. Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis. Eur. J. Cell Biol. 60 (1993) 210-216
91. Kochhar D.M., Jiang H., Harnish D.C., and Soprano D.R. Evidence that RA-induced apoptosis in the mouse limb bud core mesenchymal cells is gene-mediated. Prog. Clin. Biol. Res. 383B (1993) 815-825
92. Kojima S., Nara K., and Rifkin D.B. Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J. Cell Biol. 121 (1993) 439-448
93. Levin A.A., Sturzenbecker L.J., Kazmer S., Bosakowski T., Huselton G., Allenby C., Speck J., Kratzeisen C., Rosenberger M., Lovey A., and Grippo J.F. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355 (1992) 359-361
94. Lippmann S.M., Spitz M.R., Huber M.H., and Hong W.K. Strategies for chemoprevention study of premalignant and second primary tumors in the head and neck. Curr. Opin. Oncol. 7 (1995) 234-241
95. Lippmann S.M., Heyman R.A., Kurie J.M., Benner S.E., and Hong W.K. Retinoids and chemoprevention: clinical and basic studies. J. Cell. Biochem. 22 (1995) 1-10
96. Liu Y., Lee M.-O., Wang H.-G., Li Y., Hashimoto Y., Klaus M., Reed J.C., and Zhang X. RARβ mediates the growth inhibitory effect of retinoic acid by inducing cell apoptosis in human breast cancer cells. Mol. Cell. Biol. 16 (1996) 1138-1149
97. Los M., Van-de-Craen M., Penning L.C., Schenk H., Westendorp M., Baeuerle P.A., Droge W., Krammer P.H., Fiers W., and Schulze-Osthoff K. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375 (1995) 81-83
98. Lotan R., Xu X.C., Lippmann S.M., Ro J.Y., Lee J.S., Lee J.J., and Hong W.K. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N. Eng. J. Med. 332 (1995) 1405-1410
99. Lotan R.J. Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J. Natl. Cancer Inst. 87 (1995) 1655-1657
100. Lowe S.W., Schmitt E.M., Smith S.W., Osbome B.A., and Jacks T. P53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362 (1993) 847-849
101. Mailhos C., Howard M.K., and Latchman D.S. A common pathway mediates RA and PMA-dependent programmed cell death (apoptosis) of neuronal cells. Brain Res. 644 (1994) 7-12
102. Mangelsdorf D.J., and Evans R.M. The RXR heterodimers and orphan receptors. Cell 83 (1995) 841-850
103. Mangelsdorf D.J., Thummel C., Beato M., Herrich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., and Evans R.M. The nuclear receptor superfamily: The second decade. Cell 83 (1995) 835-839
104. Mariotti A., Marcora E., Bunone G., Costa A., Veronesi U., Pierotti M.A., and Delia Valle G. N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells. J. Natl. Cancer Inst. 86 (1994) 1245-1247
105. Marth C., Bock G., and Daxenbichler G. Effect of 4-hydroxyphenyl retinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells. J. Natl. Cancer Inst. 75 (1985) 871-875
106. Martin B., Bernardon J.M., Cavey M.T., Bernard B., Carlavan I., Charpentier B., Pilgrim W.R., Shroot B., and Reichert U. Selective synthetic ligands for human nuclear RA receptors. Skin Pharmacol. 5 (1992) 57-65
107. Martin S.J., Bradley J.G., and Cotter T.G. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol. 79 (1990) 448-453
108. Martin S.J., and Green D.R. Apoptosis and cancer: the failure of controls of cell death and cell survival. Crit. Rev. Oncol. Hematol. 18 (1995) 137-153
109. Martinez J., Chalupowicz D.G., Roush R.K., Sheth A., and Barsigian C. Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochem. 33 (1994) 2538-2545
110. Mehta K., McQueen T., Neamati N., Collins S., and Andreeff M. Activation of retinoid receptors RARα and RXRα induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Differ. 7 (1996) 179-186
111. Mehul B., Bawumia S., and Hughes R.C. Cross-linking of galectin 3, a galactose-binding protein of mammalian cells, by tissue-type transglutaminase. FEBS Lett. 360 (1995) 160-164
112. Meikrantz W., and Schlegel R. Apoptosis and the cell cycle. J. Cell Biochem. 58 (1995) 160-174
113. Melino G., Annicchiarico-Petruzzelli M., Piredda L., Candi E., Gentile V., Davies P.J., and Piacentini M. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol. Cell. Biol. 14 (1994) 6584-6596
114. Meyaard L., Otto S.A., Jonker R.R., Mijnster M.J., Keet R.P., and Miedema F. Programmed death of T cells in HIV-1 infection. Science 257 (1992) 217-219
115. Meyskens F.L., Alberts D.S., and Salmon S.E. Effect of 13-cis retinoic acid and 4-hydroxyphenyl-all-trans retinamide in human tumor-colony formation in soft agar. Int. J. Cancer 32 (1983) 295-299
116. Miura M., Zhu H., Rotello R., Hartwieg E.A., and Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75 (1993) 653-660
117. Miyashita T., and Reed J.C. Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52 (1992) 5407-5411
118. Moghal N., and Neel B.G. Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol. Cell. Biol. 15 (1995) 3945-3959
119. Moon R.C., and Mehta R.G. Chemoprevention of experimental carcinogenesis in animals. Prev. Med. 18 (1989) 576-581
120. Moon R.C., Mehta R.G., and Rao K.V.N. Retinoids and cancer in experimental anlimals. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds). The Retinoids: Biology, Chemistry and Medicine. 2nd ed. (1994), Raven Press, New York 573-596
121. Nagy L., Thomazy V.A., Shipley G.L., Fesus L., Lamph W., Heyman R.A., Chandraratna R.A., and Davies P.J. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15 (1995) 3540-3551
122. Nakamura N., Shidoji Y., Yamada Y., Hatakeyama H., Moriwaki H., and Muto Y. Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7. Biochem. Biophys. Res. Commun. 207 (1995) 382-388
123. Nakaoka H., Perez D.M., Baek K.J., Das T., Husain A., Misono K., Im M.J., and Graham R.M. Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264 (1994) 1593-1596
124. Nava M., Fabrizio T., and Arioli N. Chemoprevention of basal carcinoma by prolonged administration of the synthetic retinoid fenretinide (4-HPR). In: DePalo G., Sporn M.B., and Veronesi U. (Eds). Progress and Perspectives in Chemoprevention 79 (1992), Raven Press, New York 161-165
125. Nervi C., Vollberg T.M., George M.D., Zelent A., Chambon P., and Jetten A.M. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp. Cell Res. 195 (1991) 163-170
126. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., and Lazebnik Y.A. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376 (1995) 37-43
127. Noguchi K., Nakajima M., Naito M., and Tsuruo T. Inhibition by differentiation-inducing agents of wild-type p53-dependent apoptosis in HL-60 cells. Jpn. J. Cancer Res. 86 (1995) 217-223
128. Oberhammer F.A., Hochegger K., Froschl G., Tiefenbacher R., and Pavelka M. Chromatin condensation during apoptosis is accompanied by degradation of human lamin A+B, without enhanced activation of cdc2 kinase. J. Cell Biol. 126 (1994) 827-837
129. Oltvai Z.N., and Korsmeyer S.J. Checkpoints of dueling dimers foil death wishes. Cell 79 (1994) 189-192
130. Oltvai Z.N., Milliman C.L., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
131. Onate S.A., Tsai S.Y., Tsai M.J., and O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 (1995) 1354-1371
132. Oritani K., Kaisho T., Nakajima K., and Hirano T. RA inhibits interleukin-6-induced macrophage differentiation and apoptosis in a murine hematopoietic cell line, Y6. Blood 80 (1992) 2298-2305
133. Oridate N., Lotan D., Mitchell M.F., Hong W.K., and Lotan R. Induction of apoptosis by retinoids in human cervical carcinoma cell lines. Int. J. Oncol. 7 (1995) 433-441
134. Oridate N., Lotan D., Mitchell M.F., and Lotan R. Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemoprevention. J. Cell. Biochem. Suppl. 23 (1995) 80-86
135. Oridate N., Lotan D., Xu X.C., Hong W.K., and Lotan R. Differential induction of apoptosis by all-trans-RA and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res. (1996) in press
136. Park J.R., Robertson K., Hickstein D.D., Tsai S., Hockenbery D.M., and Collins S.J. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of RA-induced HL-60 granulocytes. Blood 84 (1994) 440-445
137. Pastorino U., Infante M., Maioli M., Chiesa G., Buyse M., and Firket P. Adjuvant treatment of stage I lung cancer with high dose vitamin A. J. Clinic. Oncol. 11 (1993) 1216-1222
138. Piacentini M., Fesus L., Farrace M.G., Ghibelli L., Piredda L., and Melino G. The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur. J. Cell. Biol. 54 (1991) 246-254
139. Piacentini M., Annicchiarico-Petruzzelli M., Oliverio S., Piredda L., Biedler J.L., and Melino E. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to RA: correlation with cell death by apoptosis. Int. J. Cancer. 52 (1992) 271-278
140. Piacentini M., Fesus L., and Melino G. Multiple cell cycle access to the apoptotic death program in human neuroblastoma cells. FEBS-Lett. 320 (1993) 150-154
141. Piacentini M., Davies P.J.A., and Fesus L. Tissue transglutaminase in cells undergoing apoptosis. In: Tomei L.D., and Cope F.O. (Eds). Apoptosis II: The Molecular Basis of Apoptosis in Disease (1994), Cold Spring Harbor Laboratory Press, New York 143-163
142. Pienta K.J., Nguyen N.M., and Lehr J.E. Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide. Cancer Res. 53 (1993) 224-226
143. Polakowska R., and Haake A.R. Apoptosis: the skin from a new perspective. Cell Death Differ. 1 (1994) 19-31
144. Pollard M., Luckert P.H., and Sporn M.B. Prevention of primary prostate cancer by 4-(hydroxyphenyl)retinamide. Cancer Res. 51 (1991) 3610-3615
145. Ponzoni M., Bocca P., Chiesa V., Decensi A., Pistoia V., Raffaghello L., Rozzo C., and Montaldo P.G. Differential effects of N-(4-hydroxyphenyl)retinamide and RA on neuroblastoma cells: apoptosis versus differentiation. Cancer Res. 55 (1995) 853-861
146. Roman S.D., Clarke C.L., Hall R.E., Alexander I.E., and Sutherland R.L. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res. 52 (1992) 2236-2242
147. Ross A.C., and Hammerling U.G. Retinoids and the immune system. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds). The Retinoids: Biology, Chemistry, and Medicine. 2nd ed. (1994), Raven Press, New York 521-544
148. Routmensz N., De Palo G., Formelli F., Costa A., Marubini E., Campa T., Crippa A., Danesini G.M., Delle Grottiglie M., Di Mauro M.G., Filiberti A., Gallazzi M., Guzzon A., Magni A., Malone W., Mariani L., Palvarini M., Perloff M., Pizzichetta M., and Veronesi U. Long term tolerability of fenretinide (4-HPR) in breast cancer patients. Eur. J. Cancer 27 (1991) 1127-1131
149. Sacks P.G., Oke V., Calkins D.P., Vasey T., and Terry N.H. Effects of β-all-trans-RA on growth, proliferation, and cell death in a multicellular tumor spheroid model for squamous carcinomas. J. Cell Physiol. 144 (1990) 237-243
150. Schott A.F., Apel I.J., Nunez G., and Clarke M.F. Bcl-XL protects cancer cells from p53-mediated apoptosis. Oncogene 11 (1995) 1389-1394
151. Schwartz L.M., Smith S.W., Jones M.E.E., and Osborne B.A. Do all programmed cell deaths occur via apoptosis? Proc. Natl. Acad. Sci. USA. 90 (1993) 980-984
152. Sedlak T.W., Oltvai Z.N., Yang E., Wang K., Boise L.H., Thompson C.B., and Korsmeyer S.J. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7834-7838
153. Seewaldt V.L., Johnson B.S., Parker M.B., Collins S.J., and Swisshelm K. Expression of RA receptor beta mediates RA-induced growth arrest and apoptosis in breast cancer cells. Cell Growth & Diff. 6 (1995) 1077-1088
154. Seifter E.G., Rettura G., and Levenson S.M. Decreased resistance of C3H/HeHa mice to C3HBA tumor transplants: increased resistance due to supplemental vitamin A. J. Natl. Cancer Inst. 67 (1981) 467-474
155. Semba R.D. Vitamin A, immunity, and infection. Clin. Infect. Dis. 19 (1994) 489-499
156. Sen S. Programmed cell death: concept, mechanism and control. Biol. Rev. 67 (1992) 287-319
157. Shan B., and Lee W.H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14 (1994) 8166-8173
158. Shao Z.M., Dawson M.I., Li X.S., Rishi A.K., Sheikh M.S., Han Q.X., Ordonez J.V., Shroot B., and Fontana J.A. P53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11 (1995) 493-504
159. Sheikh M.S., Shao Z.M., Chen J.C., Hussain A., Jetten A.M., and Fontana J.A. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor increase RAR alpha gene expression and sensitivity to growth inhibition by retinoic acid. J. Cell. Biochem. 53 (1993) 394-404
160. Sheikh M.S., Shao Z.M., Li X.S., Ordones J.V., Conley B.A., Wu S., Dawson M.I., Han Q.X., Chao W.R., Quick T., and Fontana J.A. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis 16 (1995) 2477-2486
161. Shi Y., Glynn J.M., Guilbert L.J., Cotter T.G., Bisonette R.P., and Green D.R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridoma. Science 257 (1992) 212-214
162. Smith C.A., Grimes E.A., McCarthy N.J., and Williams G.T. Multiple gene regulation of apoptosis: significance in immunology and oncology. In: Tomei L.D., and Cope F.O. (Eds). Apoptosis II: The Molecular Basis of Apoptosis in Disease. (1994), Cold Spring Harbor Laboratory Press, New York 43-87
163. Steller H. Mechanisms and genes of cellular suicide. Science 267 (1995) 1445-1449
164. Su I.J., Cheng A.L., Tsai T.F., and Lay J.D. RA-induced apoptosis and regression of a refractory Epstein-Barr virus-containing T cell lymphoma expressing multidrug-resistance phenotypes. Br. J. Haematol. 85 (1993) 826-828
165. Swisshelm K., Ryan K., Lee Tsou H.C., Peacocke M., and Sager R. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth & Diff. 5 (1994) 133-141
166. Tarcsa E., Kedei N., Thomazy V., and Fesus L. An involucrin-like protein in hepatocytes serves as a substrate for tissue transglutaminase during apoptosis. J. Biol. Chem. 267 (1992) 25648-25651
167. Tate B.F., Allenby G., Janocha R., Kazmer S., Speck J., Srurzenbecker L.J., Abarzua P., Levin A.A., and Grippo J.F. Mol. Cell. Biol. 14 (1994) 2323-2330
168. Thacher S.M., and Rice R.H. Keraunocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation. Cell 40 (1985) 685-695
169. Thompson E.B. Apoptosis and steroid hormones. Mol. Endocrinol. 8 (1994) 665-673
170. Tosi P., Visani G., Gibellini D., Zauli G., Ottaviani E., Cenacchi A., Gamberi B., Manfroi S., Marchisio M., and Tura S. All-trans RA and induction of apoptosis in acute promyelocytic leukemia cells. Leuk-Lymphom. 14 (1994) 503-507
171. Truss M., and Beato M. Steroid hormone receptors: interactions with deoxyribonucleic acid and transcriptional factors. Endocrine Rev. 14 (1993) 459-479
172. Tsai S., Bartelmez S., Heyman R., Damm K., Evans R., and Collins S.J. A mutated RA receptor-a exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes & Dev. 6 (1992) 2258-2269
173. Turley J.M., Funakoshi S., Ruscetti F.W., Kasper J., Murphy W.J., Longo D.L., and Birchenall-Roberts M.C. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and RA: role for transforming growth factor beta. Cell Growth & Diff. 6 (1995) 655-656
174. Vaux D.L. Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA 90 (1993) 786-789
175. Vaux D.L., Cory S., and Adams J.M. Bcl-2 gene promote haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335 (1988) 440-442
176. Veis D.J., Sorenson C.M., Shutter J.R., and Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic hypopigmented hair. Cell 75 (1993) 229-240
177. Veronesi U., De Palo G., Costa A., Formelli Marubini E., and Del Vecchio M. Chemoprevention of breast cancer with retinoids. J. Natl. Cancer Inst. Monogr. 12 (1992) 93-98
178. van der Burg B., van der Leede B.M., Kwakkenbos-Isbrucker L., Salverda S., and de Laat van der Saag S.W. Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol. 91 (1993) 149-157
179. vom Bauer E., Zechel C., Heery D., Heine M.J., Gamier J.M., Vivat V., Le Douarin B., Gronemeier H., Chambon P., and Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUGl and TIFl. EMBO J. 15 (1996) 110-124
180. Wallington L.A., Bunce C.M., Durham J., and Brown G. Particular combinations of signals, by RA and 1 alpha, 25 dihydroxy vitamin D3, promote apoptosis of HL60 cells. Leukemia 9 (1995) 1185-1190
181. Wang Y., Okan I., Szekely L., Klein G., and Wiman K.G. Bcl-2 inhibits wild-type p53-triggered apoptosis bt not Gl cell cycle arrest and transactivation of WAF1 and baxl. Cell Growth & Diff. 6 (1995) 1071-1075
182. Welsch C.W., DeHoog J.V., and Moon R.C. Inhibition of mammary tumorigenesis in nulliparous C3H mice by chronic feeding of the synthetic retinoid N-(4-hydroxyphenyl)retinamide. Carcinogenesis 4 (1983) 1185-1187
183. White E. Life, death and the pursuit of apoptosis. Gene & Development 10 (1996) 1-15
184. Williams G.T., and Smith C.A. Molecular regulation of apoptosis: genetic controls on cell death. Cell 74 (1993) 777-779
185. Wyllie A.H., Kerr J.F.R., and Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68 (1980) 251-306
186. Wyllie A.H., Morris R.G., Smith A.L., and Dunlop D. Chromatin cleavage in apoptosis: association with condensed morphology and dependence on macromolecular synthesis. J. Pathol. 142 (1984) 67-77
187. Yang Y., Bailey J., Vacchio M.S., Yarchoan R., and Ashwell J.D. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by RA and glucocorticoids. J. Exp. Med. 181 (1995) 1673-1682
188. Yang Y., Mercep M., Ware C.F., and Ashwell J.D. RA inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 3051-3055
189. Yang Y., Minucci S., Ozato K., Heyman R.A., and Ashwell J.D. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and RA receptors. J. Biol. Chem. 270 (1995) 18672-18677
190. Yang Y., Vacchio M.S., and Ashwell J.D. 9-Cis-RA inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6170-6174
191. Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., and Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352 (1991) 345-347
192. Yuan J. Molecular control of life and death. Curr. Opin. Cell Biol. 7 (1995) 211-214
193. Zakeri Z.F., and Ahuja U.S. Apoptotic cell death in the limb and its relationship to pattern formation. Biochem. Cell. Biol. 72 (1994) 603-613
194. Zauli G., Visani G., Vitale M., Gibellini D., Bertolaso L., and Capitani S. All-trans RA shows multiple effects on the survival, proliferation and differentiation of human fetal CD34+ haemopoietic progenitor cells. Br. J. Haematol. 90 (1995) 274-282
195. Zechel C., Shen X.Q., Chambon P., and Gronemeyer H. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements. EMBO J. 13 (1994) 1414-1424
196. Zhang L.X., and Jetten A.M. Regulation of transglutaminases and apoptosis in epithelial cells by specific retinoid receptor signaling pathways. In: Kimchi A., and Waxman S. (Eds). Differentiation Therapy. 10 (1995), Raven Press, New York 311-319
197. Zhang L.X., Mills K.J., Dawson M.I., Collins S.J., and Jetten A.M. Evidence for the involvement of RA receptor RARa-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J. Biol. Chem. 270 (1995) 6022-6029